Inhibition of LPS-induced pulmonary inflammation by specific flavonoids

L. Geraets*, A. Haegens, K. Brauers, J.A. Haydock, J.H. Vernooy, E.F. Wouters, A. Bast, G.J. Hageman

*Corresponding author for this work

    Research output: Contribution to journalArticleAcademicpeer-review

    66 Citations (Web of Science)


    In the present study, the anti-inflammatory effects of the flavonoids flavone, fisetin and tricetin were evaluated in a mouse model of LPS-induced acute pulmonary inflammation. The flavonoid fisetin significantly reduced lung myeloperoxidase-levels and gene-expression of inflammatory mediators such as IL-6, TNF-alpha, IL-1beta, MIP-1alpha and MIP-2. The LPS-induced gene transcription of HO-1 and SOD2 was also significantly reduced by fisetin. Overall, the anti-inflammatory effects of fisetin in this in vivo model were much more pronounced as compared to the observed effects of flavone or tricetin and the anti-inflammatory glucocorticoid dexamethasone. The results of this study indicate that flavonoids such as fisetin might be potential candidates as pharmaceuticals or nutraceuticals in the treatment of pulmonary inflammatory diseases.
    Original languageEnglish
    Pages (from-to)598-603
    JournalBiochemical and Biophysical Research Communications
    Issue number3
    Publication statusPublished - 1 Jan 2009

    Cite this